STSA - Satsuma Pharmaceuticals EPS beats by $0.09 November, 09 2021 05:02 PM Satsuma Pharmaceuticals Inc. Satsuma Pharmaceuticals (NASDAQ:STSA): Q3 GAAP EPS of -$0.42 beats by $0.09. Cash, cash equivalents and marketable securities of $110.15M. Press Release For further details see: Satsuma Pharmaceuticals EPS beats by $0.09